🔎 Trials Near Me

Gara Jalqabaatti › Luukemiya Limfoositiikii Keessummaa › Alabama › Birmingham

Qorannoo klinikaalii Luukemiya Limfoositiikii Keessummaa Birmingham, AL keessatti

Qorannoo 5 Luukemiya Limfoositiikii Keessummaa f Birmingham fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

Namoota walitti qabaa jiraSadarkaa 1/2
  • University of Alabama At Birmingham Hospital, Birmingham
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT05006716

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

Namoota walitti qabaa jiraSadarkaa 3
  • University of Alabama at Birmingham Cancer Center, Birmingham
Umuriin 65 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT07321652

A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Namoota walitti qabaa jiraSadarkaa 3
  • University of Alabama At Birmingham Hospital, Birmingham
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT06973187

Study of SLS009 (Formerly GFH009) a Potent Highly Selective CDK9 Inhibitor in Patients With Hematologic Malignancies and High-Risk Newly Diagnosed AML

Namoota walitti qabaa jiraSadarkaa 1/2
  • O'Neal Comprehensive Cancer Center, University of Alabama, Birmingham
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 03-Ful-2026 · NCT04588922

HPC Offered for PRESERVE Expansion

Namoota walitti qabaa jiraQorannoo ilaalaa
  • University of Alabama, Birmingham, Birmingham
Umuriin 12 hanga 80 · Saalaa hunda · Haaromfame 28-Hag-2025 · NCT07145411

Qorannoo Luukemiya Limfoositiikii Keessummaa magaalota biroo keessatti

Qorannoo biroo Birmingham keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.